ARCHIVES

Centocor Withdraws Yondelis After FDA Calls for New Study

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

CMS Withholds Coverage of CT Colonography

May 15, 2009

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010

In Brief: NCI Gets $867 Million From Conferees; Grants To Be Funded At 41-42% Including Some Holdovers

July 29, 1977

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011